rdf:type |
|
lifeskim:mentions |
umls-concept:C0006823,
umls-concept:C0009491,
umls-concept:C0010181,
umls-concept:C0020443,
umls-concept:C0032893,
umls-concept:C0033137,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0085542,
umls-concept:C0087111,
umls-concept:C0205225,
umls-concept:C0528023,
umls-concept:C1579762
|
pubmed:issue |
9
|
pubmed:dateCreated |
2001-10-8
|
pubmed:abstractText |
Potential cost differences between statins are driven primarily by drug costs, differential lowering effects on low-density lipoprotein cholesterol (LDL-C) levels, and adverse drug interactions and reactions.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0149-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1492-507
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11589262-Adolescent,
pubmed-meshheading:11589262-Adult,
pubmed-meshheading:11589262-Aged,
pubmed-meshheading:11589262-Anticholesteremic Agents,
pubmed-meshheading:11589262-Cholesterol, LDL,
pubmed-meshheading:11589262-Female,
pubmed-meshheading:11589262-Health Care Costs,
pubmed-meshheading:11589262-Humans,
pubmed-meshheading:11589262-Hypercholesterolemia,
pubmed-meshheading:11589262-Male,
pubmed-meshheading:11589262-Middle Aged,
pubmed-meshheading:11589262-Pravastatin,
pubmed-meshheading:11589262-Pyridines,
pubmed-meshheading:11589262-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: a one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness.
|
pubmed:affiliation |
University of Ottawa Heart Institute, Ontario, Canada. rmcpherson@ottawaheart.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|